Table 3.
Determinants of CTR using multivariate stepwise linear analysis in study patients
| Parameter | Multivariate (Stepwise) | |
|---|---|---|
| Unstandardized coefficient β (95% CI) | p | |
| Age (per 1 year) | 0.087 (0.038, 0.135) | 0.001 |
| Male (vs. female) | 2.953 (1.692, 4.213) | < 0.001 |
| Coronary artery disease | 1.944 (0.259, 3.630) | 0.024 |
| Cerebrovascular disease | 3.728 (1.665, 5.790) | < 0.001 |
| Body mass index (per 1 kg/m2) | 0.210 (0.055, 0.365) | 0.008 |
| Hemoglobin (per 1 g/dL) | -0.364 (-0.677, -0.050) | 0.023 |
| Uric acid (per 1 mg/dL) | 0.464 (0.185, 0.744) | 0.001 |
| Upcr (log per 1 mg/g) | 1.186 (0.130, 2.242) | 0.028 |
| Calcium-based phosphate binders use | 2.475 (0.175, 4.775) | 0.035 |
Values expressed as unstandardized coefficient β and 95% confidence interval (CI). Abbreviations are the same as in Table 1.
Adjusted for age, gender, smoking, diabetes mellitus, hypertension, coronary artery disease, cerebrovascular disease, systolic and diastolic blood pressures, body mass index, fasting glucose, log-transformed triglyceride, total cholesterol, hemoglobin, baseline eGFR, total calcium, phosphorous, calcium-phosphorous product, uric acid, PTH, log-transformed UPCR, ACEI/ARB antihypertensive drug and calcium-based phosphate binders use.